Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 214 results:
Συντάκτης [ Τίτλος] Τύπος Έτος Φίλτρα: Συντάκτης is Liakopoulos, Vassilios [Clear All Filters]
Urate crystals directly activate the T-cell receptor complex and induce T-cell proliferation..
Biomed Rep. 7(4), 365-369.
(2017). Urate crystals trigger B-cell receptor signal transduction and induce B-cell proliferation..
J Basic Clin Physiol Pharmacol. 31(4),
(2020). Uric acid and cellular and humoral alloimmunity..
J Heart Lung Transplant. 37(11), 1388.
(2018). Vascular access for hemodialysis: postoperative evaluation and function monitoring..
Int Urol Nephrol. 46(2), 403-9.
(2014). Vascular Calcification in Chronic Kidney Disease: The Role of Vitamin K- Dependent Matrix Gla Protein..
Front Med (Lausanne). 7, 154.
(2020). VEGF increases the permeability of sheep pleura ex vivo through VEGFR2 stimulation..
Cytokine. 69(2), 284-8.
(2014). Vitamin D receptor activators and response to injury in kidney diseases..
J Nephrol. 23(5), 514-24.
(2010). Vitamin K for the treatment of cardiovascular disease in End-Stage Renal Disease patients: is there hope?.
Curr Vasc Pharmacol.
(2020). VItamin K In PEritonial DIAlysis (VIKIPEDIA): Rationale and study protocol for a randomized controlled trial..
PLoS One. 17(8), e0273102.
(2022). Wave reflections and systemic vascular resistance are stronger determinants of pulse pressure amplification than aortic stiffness in drug-naïve hypertensives..
Clin Exp Hypertens. 42(3), 287-293.
(2020). Weak within-individual association of blood pressure and pulse wave velocity in hemodialysis is related to adverse outcomes..
J Hypertens. 37(11), 2200-2208.
(2019). Which blood pressure threshold indicates a therapeutic benefit for patients with chronic kidney disease?.
Hypertens Res. 46(4), 890-892.
(2023). Which is the best way for estimating transferrin saturation?.
Ren Fail. 32(8), 1022-3.
(2010). Xanthine oxidase inhibitors may prevent or slow chronic kidney disease even in the absence of hyperuricemia..
Kidney Int. 94(4), 830-831.
(2018).